<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04552444</url>
  </required_header>
  <id_info>
    <org_study_id>SAHZU2017087</org_study_id>
    <nct_id>NCT04552444</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections</brief_title>
  <official_title>Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Carbapenem resistance is a high mortality rate of Klebsiella pneumoniae infection. It has&#xD;
      been proved that high-dose carbapenem can reduce mortality and has a certain clinical effect.&#xD;
      In this study, a high dose of biapenem was compared to determine whether it had a similar&#xD;
      effect than meropenem.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>2017.01.01-2021.12.31</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clearance rate of pathogenic microorganisms</measure>
    <time_frame>2017.01.01-2021.12.31</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU hospitalization days</measure>
    <time_frame>2017.01.01-2021.12.31</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>High-dose Biapenem</condition>
  <arm_group>
    <arm_group_label>the death group</arm_group_label>
    <description>Through the corresponding treatment, the patients who died within 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the survival group</arm_group_label>
    <description>Through the corresponding treatment, the patients who survived within 28 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Biapenem</intervention_name>
    <description>In the course of CRKP treatment, double dose biapenem was selected.</description>
    <arm_group_label>the death group</arm_group_label>
    <arm_group_label>the survival group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Klebsiella pneumoniae isolated from sputum, urine and feces of patients&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Most of the patients were from the coastal areas of the Yangtze River, and some of them&#xD;
        were exposed to all parts of the country.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU hospitalized for more than 3 days;&#xD;
&#xD;
          -  Biapenem used for more than 3 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who refuse to be included in the group or pregnant women or under the age of&#xD;
             14 or ICU hospitalized for less than 3 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Man Huang, Ph D</last_name>
    <phone>+8613685753994</phone>
    <email>deter_leung@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Zhejiang University Medical College</name>
      <address>
        <city>Hangzhou</city>
        <state>Please Select</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Man Huang</last_name>
      <phone>+8613685753994</phone>
      <email>deter_leung@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</investigator_affiliation>
    <investigator_full_name>Man Huang, Ph.D</investigator_full_name>
    <investigator_title>Sponsor</investigator_title>
  </responsible_party>
  <keyword>High-dose Biapenem</keyword>
  <keyword>Carbapenem resistance Klebsiella pneumoniae</keyword>
  <keyword>Clinical Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biapenem</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

